Hem › Pulmonell hypertoni › Illinois
Kliniska studier för Pulmonell hypertoni i Illinois
6 studier för Pulmonell hypertoni söker deltagare vid platser i Illinois.
Städer i Illinois
Officiell studietext (engelska)
Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
- Northwestern University, Chicago
- University of Illinois Health, Chicago
Rekryterar
Ålder 18 och äldre · Alla kön · Uppdaterad 2 sep. 2026 · NCT06911632A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD
- Northwestern University, Chicago
RekryterarFas 3
Ålder 18 till 80 · Alla kön · Uppdaterad 2 sep. 2026 · NCT07285655A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
- Clinical Research Site, Chicago
RekryterarFas 2
Ålder 18 till 85 · Alla kön · Uppdaterad 2 sep. 2026 · NCT07333183DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- Northwestern University, Chicago
- Loyola University Medical Center, Maywood
- Advocate Christ Medical Center, Oak Lawn
RekryterarObservationsstudie
Ålder 18 och äldre · Alla kön · Uppdaterad 26 aug. 2026 · NCT06388421Deep Learning Detection of Pulmonary Hypertension and Low Ejection Fraction Via Digital Stethoscope and 3-Lead ECG
- Prairie Cardiovascular, O'Fallon
- Prairie Education & Research Cooperative, Springfield
- St Johns Hospital, Springfield, Springfield
RekryterarObservationsstudie
Ålder 18 och äldre · Alla kön · Uppdaterad 18 juni 2026 · NCT07087613Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
- University of Chicago, Chicago
- Advocate Health & Hospitals Corporation, Oakbrook Terrace
Rekryterar
Ålder 18 och äldre · Alla kön · Uppdaterad 10 juni 2026 · NCT06526195Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.